These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
170 related items for PubMed ID: 6787722
21. Renal changes in patients with rheumatoid arthritis treated with sodium thiomalate and D-penicillamine. Domljan Z, Borso G, Marinković M, Winter Fudurić I, Pucar I, Cikes N. Acta Med Iugosl; 1987; 41(5):363-72. PubMed ID: 3128058 [No Abstract] [Full Text] [Related]
22. [Side effects of gold salt therapy in patients with rheumatoid arthritis]. Vlak T, Jajić I. Reumatizam; 1992; 39(2):25-8. PubMed ID: 1366149 [Abstract] [Full Text] [Related]
23. [Continuous chrysotherapy of rheumatoid disease (evaluation of a retrospective study of 42 cases)]. D'eshougues JR, Delcambre B, Maquerlot M, Defrance D. Lille Med; 1977; 22(7):430-8. PubMed ID: 412025 [No Abstract] [Full Text] [Related]
24. [Comparative analysis of the effectiveness and tolerance of chrysanol and myochrysine in patients with rheumatoid arthritis (preliminary report)]. Slobodina GA. Ter Arkh; 1985; 57(7):131-6. PubMed ID: 2931846 [Abstract] [Full Text] [Related]
25. HLA-A,-B, and -DR antigens in relation to gold and D-penicillamine toxicity in Greek patients with RA. Pachoula-Papasteriades C, Boki K, Varla-Leftherioti M, Kappos-Rigatou I, Fostiropoulos G, Economidou J. Dis Markers; 1986 Jun; 4(1-2):35-41. PubMed ID: 3133153 [Abstract] [Full Text] [Related]
26. Corneal chrysiasis and clinical improvement with chrysotherapy in rheumatoid arthritis. Prouse PJ, Kanski JJ, Gumpel JM. Ann Rheum Dis; 1981 Dec; 40(6):564-6. PubMed ID: 6800311 [Abstract] [Full Text] [Related]
27. Erythrocyte membrane gold levels after treatment with auranofin and sodium aurothiomalate. Iqbal MS, Saeed M, Taqi SG. Biol Trace Elem Res; 2008 Dec; 126(1-3):56-64. PubMed ID: 18649049 [Abstract] [Full Text] [Related]
28. Chrysotherapy-induced aplastic anemia: a case report. Shearer CA, Parker WA. Am J Hosp Pharm; 1978 Sep; 35(9):1095-9. PubMed ID: 100010 [Abstract] [Full Text] [Related]
29. Precipitating autoantibody to a ubiquitous tissue antigen: association with rheumatoid arthritis treated with sodium aurothiomalate or d-penicillamine. Palosuo T, Kajander A, von Essen R, Milgrom F. Clin Immunol Immunopathol; 1978 Jul; 10(3):355-64. PubMed ID: 97039 [No Abstract] [Full Text] [Related]
30. [Reactions against sodium-auro-thiomalate in the treatment of rheumatoid arthritis]. Cruz Filho A, Gomes IJ, Budaruiche JS. Z Rheumatol; 1979 Jul; 38(9-10):381-4. PubMed ID: 118603 [Abstract] [Full Text] [Related]
31. Auranofin and sodium aurothiomalate in the treatment of rheumatoid arthritis. A double-blind, comparative multicenter study. Schattenkirchner M, Kaik B, Muller-Fassbender H, Rau R, Zeidler H. J Rheumatol Suppl; 1982 Jul; 8():184-9. PubMed ID: 6813483 [Abstract] [Full Text] [Related]
32. Free thiomalate levels in patients with rheumatoid arthritis treated with disodium aurothiomalate: relationship to clinical outcome of therapy. Rudge SR, Perrett D, Swannell AJ. Ann Rheum Dis; 1984 Oct; 43(5):698-702. PubMed ID: 6437348 [Abstract] [Full Text] [Related]
33. [Treatment of rheumatoid arthritis with gold salts]. Aranguena L, Hinojosa W, Chincaro C, Portugal J, Barrenechea O. Rev Clin Esp; 1984 Oct; 173(5-6):305-8. PubMed ID: 6238373 [No Abstract] [Full Text] [Related]
34. The influence of cigarette smoking on blood gold distribution during chrysotherapy. James DW, Ludvigsen NW, Cleland LG, Milazzo SC. J Rheumatol; 1982 Oct; 9(4):532-5. PubMed ID: 6813469 [Abstract] [Full Text] [Related]
35. Gold sodium thiomalate for the treatment of rheumatoid arthritis in a patient with hepatitis B. Buckley WA, Stump AL, Monger RM, Lookabill SK. Ann Pharmacother; 2011 Apr; 45(4):e23. PubMed ID: 21467262 [Abstract] [Full Text] [Related]
36. Long-term chrysotherapy in rheumatoid arthritis. Srinivasan R, Miller BL, Paulus HE. Arthritis Rheum; 1979 Feb; 22(2):105-10. PubMed ID: 105739 [Abstract] [Full Text] [Related]
37. Mucocutaneous side effects and continuation of aurotherapy in patients with rheumatoid arthritis. Taukumova LA, Mouravjoy YuV, Gribakin SG. Adv Exp Med Biol; 1999 Feb; 455():367-73. PubMed ID: 10599371 [Abstract] [Full Text] [Related]
38. Terminations of treatment with gold sodium thiomalate in rheumatoid arthritis. Sambrook PN, Browne CD, Champion GD, Day RO, Vallance JB, Warwick N. J Rheumatol; 1982 Feb; 9(6):932-4. PubMed ID: 6819360 [Abstract] [Full Text] [Related]
39. [The use of low doses of sodium aurothiomalate in the treatment of rheumatoid arthritis. Current trends in basic therapy]. Bianucci G, Maddali Bongi S, Cencetti A, Curradi C. Clin Ter; 1996 Dec; 147(12):609-20. PubMed ID: 9296920 [Abstract] [Full Text] [Related]
40. Comparison between sodium aurothiomalate and auranofin in rheumatoid arthritis. Results of a two-year open randomized study. Harth M, Davis P, Thompson JM, Menard H, Beaudet F. Scand J Rheumatol; 1987 Dec; 16(3):177-84. PubMed ID: 3110944 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]